Your browser is no longer supported. Please, upgrade your browser.
Settings
GNCA Genocea Biosciences, Inc. daily Stock Chart
GNCA [NASD]
Genocea Biosciences, Inc.
Index- P/E- EPS (ttm)-1.75 Insider Own0.40% Shs Outstand29.51M Perf Week-5.05%
Market Cap188.57M Forward P/E- EPS next Y-1.97 Insider Trans16.59% Shs Float24.92M Perf Month7.58%
Income-49.60M PEG- EPS next Q-0.54 Inst Own66.50% Short Float12.09% Perf Quarter45.23%
Sales0.20M P/S942.84 EPS this Y-0.90% Inst Trans-0.01% Short Ratio13.78 Perf Half Y71.77%
Book/sh1.60 P/B3.99 EPS next Y-3.10% ROA-56.90% Target Price13.50 Perf Year38.91%
Cash/sh2.15 P/C2.98 EPS next 5Y- ROE-76.60% 52W Range3.28 - 7.29 Perf YTD55.10%
Dividend- P/FCF- EPS past 5Y-13.10% ROI-77.30% 52W High-12.35% Beta-
Dividend %- Quick Ratio6.20 Sales past 5Y-33.60% Gross Margin- 52W Low94.82% ATR0.41
Employees98 Current Ratio6.20 Sales Q/Q-100.00% Oper. Margin- RSI (14)53.84 Volatility7.77% 7.13%
OptionableYes Debt/Eq0.37 EPS Q/Q-54.10% Profit Margin- Rel Volume0.76 Prev Close6.25
ShortableYes LT Debt/Eq0.30 EarningsMay 18 BMO Payout- Avg Volume218.57K Price6.39
Recom2.00 SMA200.85% SMA5011.78% SMA20033.10% Volume165,387 Change2.24%
Feb-17-17Downgrade Needham Buy → Hold
Apr-01-16Reiterated Stifel Buy $11 → $13
Dec-17-15Initiated UBS Buy $15
Oct-20-15Reiterated Needham Buy $22 → $15
Oct-19-15Reiterated FBR Capital Outperform $20 → $17
Mar-05-14Initiated Needham Buy $22
Mar-03-14Initiated Stifel Buy $25
Apr-27-17 08:00AM  Genocea to Host First Quarter 2017 Financial Results Conference Call & Webcast on May 4, 2017 at 9 a.m. ET GlobeNewswire -7.95%
Apr-20-17 08:15AM  GENOCEA BIOSCIENCES (GNCA) Catches Eye: Stock Gains 7.1% Zacks
Apr-19-17 11:10AM  This Trading-Range Action Is Not Offering Much TheStreet.com +7.07%
Apr-11-17 08:27AM  Genocea Awarded World Vaccine Congress 2017 Industry Excellence Award for Best Therapeutic Vaccine for GEN-003 for Genital Herpes GlobeNewswire +9.15%
Mar-29-17 08:00AM  Genocea to Present at the 16th Annual Needham Healthcare Conference GlobeNewswire +5.51%
Mar-08-17 08:30AM  Genocea Biosciences (GNCA) Jumps: Stock Moves 12% Higher Zacks
Mar-06-17 04:54PM  GENOCEA BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh
08:00AM  Howard Mayer, M.D., of Shire, Joins Genocea Biosciences Board of Directors GlobeNewswire
Mar-01-17 08:00AM  Genocea to Present at the Cowen and Company 37th Annual Health Care Conference GlobeNewswire
Feb-23-17 01:04PM  GENOCEA BIOSCIENCES, INC. Financials
Feb-22-17 11:49AM  Genocea Biosciences, Inc. :GNCA-US: Earnings Analysis: Q4, 2016 By the Numbers Capital Cube
11:49AM  Genocea Biosciences, Inc. :GNCA-US: Earnings Analysis: Q4, 2016 By the Numbers
Feb-17-17 04:06PM  GENOCEA BIOSCIENCES, INC. Files SEC form 10-K, Annual Report
07:50AM  Genocea Biosciences downgraded by Needham
Feb-16-17 07:44AM  Genocea Biosciences reports 4Q loss Associated Press -9.94%
07:38AM  GENOCEA BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
07:30AM  Genocea Reports Fourth Quarter and Year-End 2016 Financial Results GlobeNewswire
07:07AM  Q4 2016 Genocea Biosciences Inc Earnings Release - Time Not Supplied
Feb-09-17 08:00AM  Genocea to Host Fourth Quarter and Year End 2016 Financial Results Conference Call & Webcast on February 16, 2017 GlobeNewswire
Feb-07-17 08:42AM  Should You Sell Genocea Biosciences (GNCA) Before Earnings? Zacks
Jan-09-17 01:23PM  ETFs with exposure to Genocea Biosciences, Inc. : January 9, 2017
Jan-06-17 08:43AM  Genocea Stock Up on Positive Genital Herpes Infections Data -7.20%
Jan-05-17 11:40AM  Why These 5 Biopharma Stocks Are Making Massive Gains on Thursday
06:37AM  GENOCEA BIOSCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure
06:30AM  Genocea Announces Positive 6-Month Results from GEN-003 Phase 2b Clinical Trial GlobeNewswire
Dec-17-16 04:14PM  How Genocea Biosciences Inc (GNCA) Stacks Up Against Its Peers at Insider Monkey
Dec-16-16 10:15PM  How Smart Money Ranks KVH Industries, Inc. (KVHI) Against Its Peers at Insider Monkey +8.19%
Dec-14-16 04:05PM  Genocea R&D Day Highlighted Lead Program, GEN-003, for the Treatment of Genital Herpes and Introduced Immuno-Oncology Programs & Strategy GlobeNewswire
07:30AM  Genocea Announces Research Collaboration with Checkmate Pharmaceuticals in Advanced Melanoma GlobeNewswire
Dec-08-16 08:00AM  Genocea to Host Virtual R&D Day on December 14th, 2016 GlobeNewswire
Dec-01-16 08:40AM  Genocea Biosciences, Inc. :GNCA-US: Earnings Analysis: Q3, 2016 By the Numbers : December 1, 2016 -5.47%
Nov-28-16 12:00PM  Edited Transcript of GNCA earnings conference call or presentation 3-Nov-16 1:00pm GMT
Nov-11-16 07:00AM  Genoceas Proprietary ATLAS Technology Identifies Unique Candidate Antigens for Potential Personalized Cancer Vaccines GlobeNewswire +7.75%
Nov-09-16 08:00AM  Genocea to Present at Two Upcoming November Conferences GlobeNewswire
Nov-04-16 08:13AM  GENOCEA BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report
Nov-03-16 09:38AM  Genocea Biosciences reports 3Q loss -5.93%
07:40AM  GENOCEA BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
07:30AM  Genocea Reports Third Quarter 2016 Financial Results GlobeNewswire
07:07AM  Q3 2016 Genocea Biosciences Inc Earnings Release - Time Not Supplied
Oct-29-16 02:15PM  Genocea Biosciences Rises on Positive Herpes Trial Results
Oct-28-16 11:53AM  GNC Deal Could Be In Jeopardy, Genocea Taming Herpes, Opexa Not Taming MS, Plus The Latest on Theravance at Insider Monkey
07:30AM  Genocea Presents New 12 month Data on Genital Herpes Immunotherapy GEN-003 at IDWeek 2016 GlobeNewswire
Oct-27-16 08:00AM  Genocea to Host Third Quarter 2016 Financial Results Conference Call & Webcast on November 3, 2016 GlobeNewswire
Sep-29-16 10:45AM  Genocea Biosciences Posts Positive Herpes Trial Results -11.54%
07:34AM  GENOCEA BIOSCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure
07:30AM  Genoceas Genital Herpes Immunotherapy GEN-003 Demonstrates Significant Reduction of Viral Shedding in Phase 2b Clinical Trial GlobeNewswire
Aug-09-16 07:30AM  Genocea Congratulates Jessica Baker Flechtner, Ph.D. for Recognition on 2016s 40 Women To Watch Over 40 List GlobeNewswire
Aug-05-16 06:10AM  GENOCEA BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report +9.82%
Aug-04-16 08:07AM  Genocea Biosciences reports 2Q loss +5.54%
07:45AM  GENOCEA BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
07:30AM  Genocea Reports Second Quarter 2016 Financial Results GlobeNewswire
Jul-28-16 08:00AM  Genocea to Host Second Quarter 2016 Financial Results Conference Call & Webcast on August 4, 2016 GlobeNewswire
Jul-06-16 08:00AM  Genocea to Present at Cantor Fitzgeralds 2nd Annual Healthcare Conference GlobeNewswire +5.53%
Jun-29-16 07:15AM  7 Stocks Under $10 Making Big Moves
Jun-09-16 05:24PM  GENOCEA BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers -5.38%
04:30PM  Genocea Appoints Ron Cooper to Board of Directors GlobeNewswire
07:30AM  Genocea Showcases Potential of Genital Herpes Immunotherapy GEN-003 at ASM Microbe 2016 GlobeNewswire
Jun-07-16 04:22PM  GENOCEA BIOSCIENCES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-31-16 07:18AM  6 Breakout Stocks Under $10 Set to Soar +18.09%
May-23-16 07:30AM  Genocea Appoints Dr. John E. Bishop as Senior Vice President of Pharmaceutical Sciences GlobeNewswire
May-17-16 08:00AM  Genocea to Present at the 2016 UBS Global Healthcare Conference GlobeNewswire +9.97%
May-06-16 06:09AM  GENOCEA BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report -5.41%
May-05-16 09:29AM  Genocea Biosciences reports 1Q loss
08:14AM  GENOCEA BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
08:05AM  Genocea Reports First Quarter 2016 Financial Results GlobeNewswire
Apr-28-16 08:00AM  Genocea to Host First Quarter 2016 Financial Results Conference Call & Webcast on May 5, 2016 GlobeNewswire -8.18%
Apr-20-16 08:00AM  Genocea Congratulates Dr. George Siber, 2016 Albert B. Sabin Gold Medal Award Recipient GlobeNewswire
Apr-18-16 09:17AM  Biotech Quietly Preparing Technical Breakouts Accesswire
Apr-13-16 08:03AM  3 Scorching Hot Healthcare Stocks -- Are They Buys? at Motley Fool
Apr-11-16 09:30AM  Zacks Investment Ideas feature highlights: Juno Therapeutics, Genocea Biosciences, Merrimack Pharmaceuticals and BioShares Biotechnology Clinical Trials ETF -14.92%
Apr-06-16 08:00AM  Genocea to Present at the 15th Annual Needham Healthcare Conference GlobeNewswire
Apr-05-16 11:00AM  4 Small Cap Stocks That Are Getting Explosive Volume Today Accesswire
09:21AM  Genocea Biosciences (GNCA) Shares March Higher, Can It Continue?
Apr-04-16 08:42AM  Biotech Firm Receives Key Patent Notice Accesswire +14.79%
Apr-03-16 10:20AM  Top 6 Biopharma Movers of the Past Week at 24/7 Wall St.
Apr-01-16 12:52PM  Why It's Been a Wild Few Days for Genocea Biosciences Inc. at Motley Fool -23.13%
09:35AM  These Stocks Could Double In 2016 - Should They Be In Your Portfolio? Accesswire
07:00AM  Genocea's share price breaks out on herpes vaccine data at bizjournals.com
Mar-31-16 04:55PM  Here???s Why Genocea Biosciences (GNCA) Stock is Skyrocketing Today +94.96%
10:10AM  Genocea Breaks Out With Very Positive Mid-Stage Results at 24/7 Wall St.
10:06AM  Genocea Biosciences (GNCA) Stock Soars on Positive Trial Results at TheStreet
07:18AM  GENOCEA BIOSCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure
07:00AM  Genital Herpes Immunotherapy GEN-003 Shows Sustained Reduction of Viral Shedding Rate, Durable Impact on Clinical Disease 12 Months Post-Dosing GlobeNewswire
Mar-28-16 08:01AM  Biotech Sector Report Analyst Coverage Focusing on Upcoming FDA Decisions Accesswire
Mar-10-16 06:00AM  5 Stocks Under $10 Set to Soar Higher at TheStreet -5.38%
Feb-29-16 08:00AM  Genocea to Present at the Cowen and Company 36th Annual Health Care Conference GlobeNewswire +5.09%
Feb-22-16 12:10PM  Edited Transcript of GNCA earnings conference call or presentation 11-Feb-16 2:00pm GMT -5.12%
Feb-17-16 05:05PM  GENOCEA BIOSCIENCES, INC. Files SEC form 10-K, Annual Report +5.44%
Feb-12-16 06:04AM  5 Breakout Stocks to Trade for Big Gains at TheStreet +21.59%
Feb-11-16 09:00AM  Genocea Biosciences Inc Earnings Call scheduled for 9:00 am ET today +9.45%
07:56AM  GENOCEA BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
07:30AM  Genocea Reports Fourth Quarter and Year-End 2015 Financial Results GlobeNewswire
07:07AM  Q4 2015 Genocea Biosciences Inc Earnings Release - Before Market Open
Feb-04-16 08:00AM  Genocea to Host Fourth Quarter and Year End 2015 Financial Results Conference Call & Webcast on February 11, 2016 GlobeNewswire
Feb-01-16 07:02PM  Genocea Doses Patients in Phase IIb Study on GEN-003
08:20AM  Genocea to Present at 2016 BIO CEO & Investor Conference at noodls
08:00AM  Genocea to Present at 2016 BIO CEO & Investor Conference GlobeNewswire
Jan-29-16 08:31AM  Genocea Commences Dosing in Phase 2b Study for Genital Herpes Treatment, GEN-003 at noodls -5.18%
08:00AM  Genocea Commences Dosing in Phase 2b Study for Genital Herpes Treatment, GEN-003 GlobeNewswire
Jan-26-16 10:15AM  Genocea to study drugs that can combine with Opdivo, Keytruda at bizjournals.com
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel vaccines and immunotherapies to treat infectious diseases. The company uses its proprietary discovery platform AnTigen Lead Acquisition System to design vaccines and immunotherapies that act through T cell immune responses. Its lead product candidate is GEN-003, a therapeutic vaccine or immunotherapy that is in Phase 2 trial for the treatment of genital herpes infections. The company is also developing GEN-009, which is in pre-clinical stage for the treatment of immuno-oncology-neoantigen; and GEN-007 that is in research stage for the treatment of Epstein-Barr virus. Genocea Biosciences, Inc. was founded in 2006 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HETHERINGTON SETH VChief Medical OfficerNov 09Option Exercise2.025,00010,10026,000Nov 09 05:38 PM
Hoffman Eric SChief Business OfficerNov 08Buy3.593,00010,77011,790Nov 09 05:30 PM
Poole JonathanChief Financial OfficerNov 07Buy3.347,00023,38017,213Nov 09 05:32 PM
Clark William DPresident and CEONov 07Buy3.492,8009,77252,205Nov 09 05:29 PM
Hoffman Eric SChief Business OfficerNov 07Buy3.414,00013,6408,790Nov 09 05:30 PM
Poole JonathanChief Financial OfficerMay 09Buy3.884,00015,5208,213May 10 04:25 PM